Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Eksterne analyser

Ogunsen: Waiting for the recovery to start - ABG

Ogunsen

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier.

Download analyse (PDF)
Organic sales decline of 7% y-o-y
EBIT margin of 7.6% (7.9%)
Positive signs in the recruiting business


Demand still muted but profitability improves q-o-q

Ogunsen reported Q3 sales of SEK 103m (111m), down 7% y-o-y and 7% behind ABGSCe. The y-o-y drop was caused by lower staffing revenues. Recruiting revenues, on the other hand grew 5% y-o-y, marking the first quarter with growth since Q3'22, which is a positive signal. The revenue mix helped improve profitability from the levels seen in Q2, as the recruiting business usually has higher profitability. EBIT was SEK 7.8m (8.7m) for an EBIT margin of 7.6% (7.9%); this was 10% above ABGSCe. FCF was negative in Q3 from a timing issue and a subsequent working capital build-up. We have no reason to believe this a long-term issue, and think it will revert in Q4.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.